Request edit access
JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.
109年度疑陽課程-10/31(六)北區三總場-課前測驗
應國健署要求,學會需收集疑陽教育訓練課程參與學員之前測成績及後測成績,用以分析課程學習成效
懇請報名參加此場課程的學員,協助完成以下前測表單,以利學會後續作業,感謝各位學員的配合與協助!
***報到注意事項:
1.為配合防疫措施,場地禁止飲食,懇請海涵。
2.請務必全程配戴口罩,未配戴口罩者不得進入會議場地。
3.報到時,請先在學會報到處簽到,再去簽您要的教育積分,兩者缺一不可(缺其一則無法認證教育積分)。
Sign in to Google
to save your progress.
Learn more
* Indicates required question
姓名
*
Your answer
報到編號(請見學會官網公告或寄發之報到通知Email中的附件,現場報名者請填"現場報名")
Your answer
請問您的身份是?
*
外科醫師
放射科醫師
其他科醫師
行政人員
超音波檢查員 (放射師/醫檢師/護理人員)
護理人員(不執行超音波)
Q1.胸部自體脂肪移植後的乳房腫塊,�下列那一項為其在乳房超音波最常見的表徵?
*
1.Oil Cyst
2.Complex Cyst
3.Solid mass
4.Microcalcification
Q2.做過果凍矽膠隆乳手術後追蹤,�乳房超音波檢查發現下圖的變化,�醫師懷疑義乳可能破裂,�請問下列超音波報告病灶的描述何者較為適當?
*
1. Stepladder
2. Snowstorm
3. Mass
4. Anechoic
Q3.做過果凍矽膠隆乳手術後追蹤,�乳房超音波檢查發現下圖的變化,�請問下列超音波報告病灶的描述何者較為適當?
*
1. Linguine
2. Reverberation artifact
3. Radial folds
4. Snowstorm
Q4.下列何者非Suspicious Calcification之morphology?
*
1. Fine pleomorphic
2. Amorphous
3. Fine linear and branching
4. Dystrophic
Q5.下列有關amorphous calcifications�何者為非?
*
1. 60% benign, especially when diffuse and benign.
2. 20% high risk lesions, such as atypical ductal hyperplasia, lobular carcinoma in situ.
3. 20% malignant, such as low grade DCIS, invasive ductal carcinoma.
4. 20 % malignant, such as lobular carcinoma in situ, phyllodes tumor.
Q6.下列有關Calcifications morphology�在 5th Edition 2013 ACR-BIRADS中,�何者為非?
*
1.分typically benign and suspicions morphology
2.分benign, intermediate concern and high probability of malignancy.
3.Typically benign 包含skin, vascular, coarse/ popcorn, milk of calcium.
4.Suspicious morphology 包括fine pleomorphic, fine linear or fine linear bracnching
Q7. The recommend MAXIMAL life-time accumulative dose of Epirubicin is :
*
1. 600mg/m2
2. 700mg/m2
3. 800mg/m2
4. 900mg/m2
Q8. Which cardiac markers can be used to monitor chemotherapy related �cardiac injury/cardiomyopathy?
*
1. CK-MB and ALP
2. CK-MB and troponins
3. Troponins and natriuretic peptides
4. BUN and natriuretic peptides
Q9. Which statement is INCORRECT?
*
1. Venous thrombosis should be considered when we use bevacizumab
2. QTc prolongation is a potentially serious side effect of Palbociclib
3. Trastuzumab-induced heart failure is usually reversible
4. There is NO recommended maximal life-time accumulative dose of Liposomal doxorubicin
Submit
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. -
Terms of Service
-
Privacy Policy
Does this form look suspicious?
Report
Forms
Help and feedback
Contact form owner
Help Forms improve
Report